{"id":"CHEMBL1079905","canonicalSmiles":"CCCn1cnc2c1c(=O)n(CCCCC(C)=O)c(=O)n2C","inchiKey":"RBQOQRRFDPXAGN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPENTOFYLLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HWA 285","Propentofylline"],"crossReferences":{"PubChem":["104171224","11111693","144203798","170465624","26753633","49645640","50106916","85231201","90340930"],"drugbank":["DB06479"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1085699","canonicalSmiles":"COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN2CCN(C(c3ccccc3)c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1","inchiKey":"ANEBWFXPVPTEET-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MANIDIPINE 6300","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Manidipine","Manidipine 6300","Manidipine hydrochloride"],"crossReferences":{"PubChem":["174006297","50112746"],"drugbank":["DB09238"]},"childChemblIds":["CHEMBL2362693"],"count":2,"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000102001","ENSG00000151067"],"count":4},"linkedDiseases":{"rows":["EFO_0000319","EFO_0000537"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL112834","canonicalSmiles":"CCCCn1c(Cc2ccc(OC)cc2)nc2c(N)ncnc21","inchiKey":"NVYATAJRTRFKSW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL112834","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03899"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1159","canonicalSmiles":"CC(N/C(=N\\C#N)Nc1ccncc1)C(C)(C)C","inchiKey":"IVVNZDGDKPTYHK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PINACIDIL","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pindac"],"synonyms":["Pinacidil"],"crossReferences":{"PubChem":["11532877","124881033","26749106","26752206","50104869","56463565","90341497"],"Wikipedia":["Pinacidil"],"drugbank":["DB06762"]},"childChemblIds":["CHEMBL1200338"],"linkedTargets":{"rows":["ENSG00000069431"],"count":1},"linkedDiseases":{"rows":["EFO_0000537"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1989."}
{"id":"CHEMBL1183717","canonicalSmiles":"C=CCNc1nc(NCC=C)nc(N2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)n1","inchiKey":"OBDOVFRMEYHSQB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALMITRINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Almitrine"],"crossReferences":{"drugbank":["DB01430"],"chEBI":["53778"]},"childChemblIds":["CHEMBL314610","CHEMBL3181957"],"count":2,"approvedIndications":["EFO_0000684"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for respiratory system disease and has 1 investigational indication."}
{"id":"CHEMBL1185","canonicalSmiles":"CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12","inchiKey":"ULSDMUVEXKOYBU-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOLMITRIPTAN","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zolmitriptan","Zomig","Zomig-zmt"],"synonyms":["311-C-90","311C90","Zolmitriptan"],"crossReferences":{"DailyMed":["zolmitriptan"],"PubChem":["144205008","170464875"],"Wikipedia":["Zolmitriptan"],"drugbank":["DB00315"],"chEBI":["10124"]},"count":1,"approvedIndications":["EFO_0003821"],"linkedTargets":{"rows":["ENSG00000135312","ENSG00000179546"],"count":2},"linkedDiseases":{"rows":["EFO_0003821","EFO_0003843"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997 and is indicated for migraine disorder."}
{"id":"CHEMBL1200335","canonicalSmiles":"CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"VOCBWIIFXDYGNZ-IXKNJLPQSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TESTOSTERONE ENANTHATE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Delatestryl","Primoteston depot","Testosterone enanthate","Xyosted (autoinjector)"],"synonyms":["NSC-17591","Testosterone enantate","Testosterone enanthate","Testosterone enanthate ciii","Testosterone heptanoate"],"crossReferences":{"DailyMed":["testosterone%20enanthate"],"drugbank":["DB13944"],"chEBI":["9464"]},"count":9,"approvedIndications":["HP_0000044","MONDO_0002146"],"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["HP_0000044","EFO_1000653","EFO_0007312","MONDO_0002146","EFO_0000673","EFO_0000196","Orphanet_269","EFO_0000341","HP_0001824","MONDO_0008315","MONDO_0018555"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1953 and is indicated for hypogonadism and hypogonadotropic hypogonadism and has 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200384","canonicalSmiles":"CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C","inchiKey":"CIWBQSYVNNPZIQ-XYWKZLDCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAMETHASONE DIPROPIONATE","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alphatrex","Betamethasone dipropionate","Diprolene","Diprolene af","Diprosone","Sernivo"],"synonyms":["Betamethasone 17,21-dipropionate","Betamethasone dipropionate","SCH 11460","SCH-11460"],"crossReferences":{"DailyMed":["betamethasone%20dipropionate"],"PubChem":["144206894","29215385"],"Wikipedia":["Betamethasone_dipropionate"],"chEBI":["31276"]},"count":11,"approvedIndications":["HP_0006536","EFO_1001494","EFO_0000544","EFO_0000701","EFO_0000676","EFO_0009552","HP_0001742","EFO_0005752"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_1001097","HP_0006536","EFO_1001494","EFO_0000544","EFO_0000701","EFO_0000676","EFO_0004143","EFO_0009552","EFO_0000274","EFO_0008517","HP_0001742","HP_0004798","EFO_0005752"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1975 and has 8 approved and 3 investigational indications."}
{"id":"CHEMBL1200408","canonicalSmiles":"COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[n-]2)c1OC.[Na+]","inchiKey":"YNWDKZIIWCEDEE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PANTOPRAZOLE SODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1502","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Pantoprazole Sodium","Protonix","Protonix Iv"],"synonyms":[],"crossReferences":{"PubChem":["144206548","144212679"],"chEBI":["50270"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200432","canonicalSmiles":"CCOC(=O)[C@@](C)(N)Cc1ccc(O)c(O)c1.Cl","inchiKey":"QSRVZCCJDKYRRF-YDALLXLXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLDOPATE HYDROCHLORIDE","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201233","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aldomet","Methyldopate hydrochloride"],"synonyms":["Methyldopa l-form ethyl ester hydrochloride","Methyldopate hydrochloride"],"crossReferences":{"PubChem":["144204076","170466856"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1962."}
{"id":"CHEMBL1200459","canonicalSmiles":"O=P([O-])([O-])O.[K+].[K+]","inchiKey":"ZPWVASYFFYYZEW-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM PHOSPHATE, DIBASIC","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Isolyte","Neutra-Phos"],"synonyms":["Dibasic potassium phosphate","E-340(II)","INS NO.340(II)","INS-340(II)","Potassium phosphate dibasic","Potassium phosphate, dibasic"],"crossReferences":{"DailyMed":["potassium%20phosphate,%20dibasic"],"DrugCentral":["4206"],"Wikipedia":["Dipotassium_phosphate"],"drugbank":["DB09414"],"chEBI":["32031"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1200491","canonicalSmiles":"Cl.NC1=NCC2c3ccccc3Cc3ccccc3N12","inchiKey":"VKXSGUIOOQPGAF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPINASTINE HYDROCHLORIDE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1106","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Elestat","Epinastine hydrochloride","Relestat"],"synonyms":["DE-114","Epinastine HCl","Epinastine hydrochloride","WAL 801 CL","WAL-801CL","WAL-802-CL"],"crossReferences":{"DailyMed":["epinastine%20hydrochloride"],"PubChem":["144205816","170465284"],"chEBI":["51037"]},"count":1,"approvedIndications":["EFO_0007141"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0007141"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2003 and is indicated for allergic conjunctivitis."}
{"id":"CHEMBL1200667","canonicalSmiles":"CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"PYTMYKVIJXPNBD-BTKVJIOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENCLOMIPHENE CITRATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL954","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Androxal"],"synonyms":["Enclomiphene citrate"],"crossReferences":{"PubChem":["11532948"],"Wikipedia":["Clomifene"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1200706","canonicalSmiles":"[Al+3].[OH-].[OH-].[OH-]","inchiKey":"WNROFYMDJYEPJX-UHFFFAOYSA-K","drugType":"Small molecule","blackBoxWarning":false,"name":"ALUMINUM HYDROXIDE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alu-cap","Aludrox","Amphojel","Dialume","Sarpep"],"synonyms":["Aluminium hydroxide","Aluminium hydroxide gel, dried","Aluminum hydroxide","Dried aluminum hydroxide gel","NSC-664400"],"crossReferences":{"Wikipedia":["Aluminium_hydroxide"],"drugbank":["DB06723"],"chEBI":["33130"]},"childChemblIds":["CHEMBL3833310","CHEMBL3833390"],"count":20,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1983 and has 20 investigational indications."}
{"id":"CHEMBL1200885","canonicalSmiles":"Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O.Cl","inchiKey":"FNYQZOVOVDSGJH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ALOSETRON HYDROCHLORIDE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1110","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alosetron hydrochloride","Lotronex"],"synonyms":["Alosetron hydrochloride","GR 68755C","GR-68755C"],"crossReferences":{"DailyMed":["alosetron%20hydrochloride"],"PubChem":["144206078","170465416","49681825"],"chEBI":["53783"]},"count":1,"approvedIndications":["EFO_0000555"],"linkedTargets":{"rows":["ENSG00000166736"],"count":1},"linkedDiseases":{"rows":["EFO_0000555"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2000 and is indicated for irritable bowel syndrome. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200941","canonicalSmiles":"Cc1ncc(C[n+]2csc(CCO)c2C)c(N)n1.Cl.[Cl-]","inchiKey":"DPJRMOMPQZCRJU-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"THIAMINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1547","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Benerva","Betalin s","Bevitine","Bevitol","Thiamine hydrochloride","Tyvera","Vit b1","Vit b1 thiamin"],"synonyms":["Aneurine hydrochloride","FEMA NO. 3322","NSC-36226","Thiamine Disulfide","Thiamine chloride hydrochloride","Thiamine hydrochloride","Thymine hydrochloride","Vitamin b1"],"crossReferences":{"DailyMed":["thiamine%20hydrochloride"],"PubChem":["11112929","144204287","56320769","56320770"],"chEBI":["49105"]},"count":4,"approvedIndications":["EFO_0004272","HP_0001891"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for iron deficiency anemia and anemia (phenotype) and has 2 investigational indications."}
{"id":"CHEMBL1200945","canonicalSmiles":"O=C([O-])CN(CCN(CC(=O)[O-])CC(=O)[O-])CCN(CC(=O)[O-])CC(=O)[O-].[Ca+2].[Na+].[Na+].[Na+]","inchiKey":"AYFCVLSUPGCQKD-UHFFFAOYSA-I","drugType":"Small molecule","blackBoxWarning":true,"name":"PENTETATE CALCIUM TRISODIUM","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL780","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pentetate calcium trisodium"],"synonyms":["Calcium trisodium pentetate","NSC-34249","Pentetate calcium trisodium"],"crossReferences":{"DailyMed":["pentetate%20calcium%20trisodium"],"DrugCentral":["4753"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200968","canonicalSmiles":"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+]","inchiKey":"RYJIRNNXCHOUTQ-OJJGEMKLSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCORTISONE SODIUM PHOSPHATE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1641","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Efcortesol","Hydrocortone"],"synonyms":["Hydrocortisone sodium phosphate"],"crossReferences":{"PubChem":["144206021"],"chEBI":["5781"]},"count":2,"approvedIndications":["EFO_0009552","EFO_0005752"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0009552","HP_0004798","EFO_0005752"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1960 and is indicated for eye inflammation and hemorrhoid."}
{"id":"CHEMBL1201060","canonicalSmiles":"CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1.Cl","inchiKey":"JSXBVMKACNEMKY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOXAPINE HYDROCHLORIDE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL831","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Loxitane c","Loxitane im"],"synonyms":["Loxapine HCl","Loxapine hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1976."}
{"id":"CHEMBL1201156","canonicalSmiles":"CNCCC=C1c2ccccc2CCc2ccccc21.Cl","inchiKey":"SHAYBENGXDALFF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NORTRIPTYLINE HYDROCHLORIDE","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL445","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aventyl","Aventyl hydrochloride","Nortriptyline hydrochloride","Pamelor","Psychostyl"],"synonyms":["38489","NSC-169453","Nortriptyline hydrochloride"],"crossReferences":{"DailyMed":["nortriptyline%20hydrochloride"],"PubChem":["144203599","50106715","50106716","562776","56423135","855575"]},"count":4,"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["EFO_0008524","EFO_0000676","EFO_1000948","EFO_0000274"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201196","canonicalSmiles":"Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1","inchiKey":"JLGKQTAYUIMGRK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SERTACONAZOLE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Demofix","Ertaczo","FI-7045","Sertaconazole"],"crossReferences":{"DailyMed":["sertaconazole%20nitrate"],"Wikipedia":["Sertaconazole"],"drugbank":["DB01153"],"chEBI":["83682"]},"childChemblIds":["CHEMBL1200725"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2003 and has 1 investigational indication."}
{"id":"CHEMBL1201208","canonicalSmiles":"CC1NCCOC1c1ccccc1","inchiKey":"OOBHFESNSZDWIU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENMETRAZINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Phenmetrazine","Preludin"],"crossReferences":{"Wikipedia":["Phenmetrazine"],"drugbank":["DB00830"],"chEBI":["8067"]},"childChemblIds":["CHEMBL1200483"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201220","canonicalSmiles":"CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I","inchiKey":"YVPYQUNUQOZFHG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIATRIZOIC ACID","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Amidotrizoic acid","Diatrizoic acid","NSC-262168"],"crossReferences":{"DailyMed":["diatrizoate%20meglumine","diatrizoate%20sodium"],"PubChem":["144212246"],"Wikipedia":["Diatrizoic_acid"],"drugbank":["DB00271"],"chEBI":["53691"]},"childChemblIds":["CHEMBL3188504","CHEMBL1200581","CHEMBL1534228","CHEMBL2106216","CHEMBL1200839"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1954."}
{"id":"CHEMBL1201273","canonicalSmiles":"CC(Cc1ccc2c(c1)OCO2)NCC(O)c1ccc(O)c(O)c1","inchiKey":"LUMAEVHDZXIGEP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROTOKYLOL","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Asmeti","Caytine","Palisan","Protokylol","Ventaire"],"crossReferences":{"Wikipedia":["Protokylol"],"drugbank":["DB06814"]},"childChemblIds":["CHEMBL1200893"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201274","canonicalSmiles":"CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1","inchiKey":"NWIUTZDMDHAVTP-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOBETAXOLOL","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Levobetaxolol"],"crossReferences":{"Wikipedia":["Levobetaxolol"],"drugbank":["DB09351"],"chEBI":["59254"]},"childChemblIds":["CHEMBL1200837"],"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["EFO_1001069","EFO_0000516"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2000."}
{"id":"CHEMBL1201303","canonicalSmiles":"Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1","inchiKey":"QMHSXPLYMTVAMK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRVINIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Pyrvinium"],"crossReferences":{"Wikipedia":["Pyrvinium"],"drugbank":["DB06816"],"chEBI":["8687"]},"childChemblIds":["CHEMBL1908377","CHEMBL4303307","CHEMBL2105340","CHEMBL1572280"],"count":1,"approvedIndications":["EFO_1001342"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for helminthiasis."}
{"id":"CHEMBL1201569","drugType":"Unknown","blackBoxWarning":true,"name":"BOTULINUM TOXIN TYPE B","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Myobloc","Neurobloc"],"synonyms":["AN-0772","Botulin b","Botulinum toxin type b"],"crossReferences":{"DailyMed":["botulinum%20toxin%20type%20b"]},"count":8,"linkedTargets":{"rows":["ENSG00000220205"],"count":1},"linkedDiseases":{"rows":["HP_0200042","EFO_0000275","HP_0000726","HP_0000473","HP_0009762","EFO_1000632","HP_0000975","HP_0003419","EFO_0004143","HP_0002307"],"count":10},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201731","canonicalSmiles":"Cl.OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1","inchiKey":"JWEXHQAEWHKGCW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEBIVOLOL HYDROCHLORIDE","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL434394","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bystolic","Nebivolol hydrochloride"],"synonyms":["Nebivolol hydrochloride","R-067555","R067555","RO67555"],"crossReferences":{"DailyMed":["nebivolol%20hydrochloride"]},"count":1,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591"],"count":2},"linkedDiseases":{"rows":["EFO_0000537"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2007 and is indicated for hypertension."}
{"id":"CHEMBL1206690","canonicalSmiles":"CCC(=O)NS(=O)(=O)c1ccc(-c2c(-c3ccccc3)noc2C)cc1","inchiKey":"TZRHLKRLEZJVIJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PARECOXIB","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Parecoxib","SC-69124"],"crossReferences":{"Wikipedia":["Parecoxib"],"drugbank":["DB08439"],"chEBI":["73038"]},"childChemblIds":["CHEMBL296913"],"count":5,"approvedIndications":["EFO_0005755"],"linkedTargets":{"rows":["ENSG00000073756"],"count":1},"linkedDiseases":{"rows":["EFO_1001412","EFO_1000218","EFO_0003931","EFO_0002506","HP_0030834","EFO_1002012","EFO_0003843","EFO_0005755","EFO_1000635"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for rheumatic disease and has 4 investigational indications."}
{"id":"CHEMBL1229950","canonicalSmiles":"C=CCc1ccccc1O","inchiKey":"QIRNGVVZBINFMX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-ALLYLPHENOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Allylphenol"],"crossReferences":{"PubChem":["144212373"],"drugbank":["DB02534"],"chEBI":["39826"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230165","canonicalSmiles":"O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12","inchiKey":"MUOKSQABCJCOPU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SILMITASERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CX 4945","CX-4945","CX4945","Cx-4945","Silmitasertib"],"crossReferences":{"PubChem":["137276036"],"drugbank":["DB15408"]},"count":4,"linkedTargets":{"rows":["ENSG00000101266"],"count":1},"linkedDiseases":{"rows":["MONDO_0100096","EFO_0002939","EFO_0001378","EFO_0004193","EFO_0005221"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1230790","canonicalSmiles":"CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21","inchiKey":"MWYBBCLGEHZSCP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230790","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07335"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231847","canonicalSmiles":"Cc1ccc(S(=O)(=O)NCCCOC(=O)Nc2ccncc2)cc1","inchiKey":"ITYCDQJBLCTIID-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231847","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["4241792"],"drugbank":["DB07572"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233401","canonicalSmiles":"CCCCCCCc1cc(O)c2ccccc2[n+]1[O-]","inchiKey":"NZPACTGCRWDXCJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233401","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07918"],"chEBI":["28362"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233515","canonicalSmiles":"C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](OC[C@H]3O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"FZLCJZILHGFQLM-PISLJJGOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233515","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03495"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236184","canonicalSmiles":"Cc1ncnc2c1ncn2[C@@H]1O[C@H]([C@H](C)O)[C@@H](O)[C@H]1O","inchiKey":"XJZDIUOABWMPLZ-DSBXBFMBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236184","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02934"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236924","canonicalSmiles":"O=S(=O)(Nc1cc(Cl)c(Oc2cnc3ccccc3c2)c(Cl)c1)c1ccc(Cl)cc1Cl","inchiKey":"NMRWDFUZLLQSBN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INT131","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-131","Int131","T0903131","T131"],"crossReferences":{"drugbank":["DB05490"]},"count":2,"linkedTargets":{"rows":["ENSG00000132170"],"count":1},"linkedDiseases":{"rows":["EFO_0003929","EFO_0001360"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1256658","canonicalSmiles":"CN(C)CC/C=C1/c2ccccc2Sc2ccc(Cl)cc21.Cl","inchiKey":"YWKRLOSRDGPEJR-KIUKIJHYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORPROTHIXENE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL908","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlorprothixene HCl"],"crossReferences":{"PubChem":["56423655"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1256818","canonicalSmiles":"Br.COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3.O","inchiKey":"STTADZBLEUMJRG-IKNOHUQMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTROMETHORPHAN HYDROBROMIDE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL52440","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Beecham coughcaps","Benylin dm","Brontyl","Contac coughcaps","Delsym","Dextromethorphan hydrobromide oros tablets","Drixoral cough","Franolyn dry","Franolyn sed","Pediacare 1","Romilar","Tussabron","Tuxium"],"synonyms":["Dextromethorphan Hydrobromide Monohydrate","Dextromethorphan hydrobromide"],"crossReferences":{"DailyMed":["dextromethorphan%20hydrobromide"],"PubChem":["11112982","26732619","49731998"]},"count":11,"approvedIndications":["EFO_0007486","HP_0012735","EFO_0007214","EFO_0003785"],"linkedTargets":{"rows":["ENSG00000183454","ENSG00000147955"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0002050","EFO_0007486","HP_0012735","MONDO_0002009","EFO_0000544","EFO_0003821","EFO_0009321","EFO_0001360","EFO_0003843","EFO_0007214","EFO_0003785","EFO_0001663"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and has 4 approved and 7 investigational indications."}
{"id":"CHEMBL134920","canonicalSmiles":"Cn1c([N+](=O)[O-])cnc1/C=C/c1ccnc(N)n1","inchiKey":"LHIALLMPKJMSIQ-NSCUHMNNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZANIDAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azanidazole"],"crossReferences":{"Wikipedia":["Azanidazole"],"drugbank":["DB13350"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1360024","canonicalSmiles":"Cn1nnnc1SCC1=C(C(=O)[O-])N2C(=O)[C@@H](NC(=O)[C@H](O)c3ccccc3)[C@H]2SC1.[Na+]","inchiKey":"OJMNTWPPFNMOCJ-CFOLLTDRSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFAMANDOLE SODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1146","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cefamandole sodium"],"crossReferences":{"PubChem":["144204328","855600"],"chEBI":["34614"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1382627","canonicalSmiles":"Nc1ccc(S(=O)(=O)[N-]c2ncccn2)cc1.[Ag+]","inchiKey":"UEJSSZHHYBHCEL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFADIAZINE, SILVER","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL439","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Flamazine","Flammacerium","Sildaflo","Silvadene","Ssd af","Thermazene"],"synonyms":["Silver sulfadiazine","Sulfadiazine silver","Sulfadiazine silver salt","Sulfadiazine, silver"],"crossReferences":{"DailyMed":["silver%20sulfadiazine"],"DrugCentral":["4142"],"PubChem":["124894330","144206550","144207020","8139967"],"drugbank":["DB05245"],"chEBI":["9142"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and has 3 investigational indications."}
{"id":"CHEMBL1398657","canonicalSmiles":"O=S(=O)(O)c1ccc(O)cc1","inchiKey":"FEPBITJSIHRMRT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENOLSULFONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phenolsulfonic acid"],"crossReferences":{"PubChem":["144205718","170465916","26757953"],"drugbank":["DB14739"],"chEBI":["32354"]},"childChemblIds":["CHEMBL3989534"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL142348","canonicalSmiles":"C[C@@]12C=CC[C@H]1[C@@H]1CC[C@H]3C[C@H](O)CC[C@]3(C)[C@H]1CC2","inchiKey":"KRVXMNNRSSQZJP-PHFHYRSDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANDROSTENOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Androstenol"],"crossReferences":{"PubChem":["26756468"],"Wikipedia":["Androstenol"],"drugbank":["DB01889"],"chEBI":["40933"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL142996","canonicalSmiles":"N#C/C(C(=O)Nc1ccc(-c2ccccc2)cc1)=C(/O)C1CC1","inchiKey":"CAGGGMPTWTUYHZ-ZCXUNETKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL142996","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08169"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1451633","canonicalSmiles":"O=C(OCCOCCO)c1ccccc1Nc1cccc(C(F)(F)F)c1","inchiKey":"XILVEPYQJIOVNB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETOFENAMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY D 1107","Etofenamate","TVX485","WHR-5020"],"crossReferences":{"PubChem":["11112716","144204169","170466266"],"drugbank":["DB08984"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL146245","canonicalSmiles":"CC(=O)OC1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O","inchiKey":"FYRWUTOZBRWYCS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL146245","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14672"]},"childChemblIds":["CHEMBL3251469"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1473","canonicalSmiles":"CCC(=O)O[C@]1(C(=O)SCF)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C","inchiKey":"WMWTYOKRWGGJOA-CENSZEJFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUTICASONE PROPIONATE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aerivio spiromax","Airflusal forspiro","Armonair digihaler","Armonair respiclick","Cutivate","Flixonase","Flixotide","Flonase","Flonase allergy relief","Flovent","Flovent diskus 100","Flovent diskus 250","Flovent diskus 50","Flovent hfa","Fluticasone propionate","Flutiform","Nasofan","Pirinase","Sereflo","Seretide 100","Seretide 125","Seretide 250","Seretide 50","Seretide 500","Sirdupla","Xhance"],"synonyms":["CCI 18781","CCI-18781","FLOVENT","Fluticasone","Fluticasone propionate","Fluticasone propionate ","Opn-375","PF-00241939"],"crossReferences":{"DailyMed":["fluticasone%20propionate"],"Wikipedia":["Fluticasone_propionate"],"drugbank":["DB00588"],"chEBI":["31441"]},"count":24,"approvedIndications":["EFO_0005854","HP_0006536","EFO_0000270","EFO_0000464","EFO_0006505","EFO_0000701","EFO_0000341","EFO_0000274","HP_0001742","EFO_0003956"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0007486","EFO_0007183","EFO_0000464","EFO_0010638","EFO_0009536","EFO_0000274","HP_0011950","EFO_0000676","EFO_0004208","EFO_1001417","EFO_0000400","EFO_0005854","EFO_0008521","EFO_0000701","EFO_1000024","EFO_0000662","HP_0010307","EFO_1001942","HP_0001742","EFO_0004232","EFO_0007227","HP_0006536","EFO_1000391","EFO_0000270","EFO_0006505","EFO_0000341","HP_0025428","EFO_0007141","EFO_0003918","EFO_0003956","EFO_0003785"],"count":31},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and has 10 approved and 14 investigational indications."}
{"id":"CHEMBL151515","canonicalSmiles":"CN1CCC[C@H]1c1cccnc1.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O","inchiKey":"RFEJUZJILGIRHQ-XRIOVQLTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL151515","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1520188","canonicalSmiles":"O=P([O-])(O)C(Cl)(Cl)P(=O)([O-])O.[Na+].[Na+]","inchiKey":"HJKBJIYDJLVSAO-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CLODRONATE DISODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL12318","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Bonefos"],"synonyms":["177501","Clodronate disodium","Clodronic acid disodium salt","Clodronic acid disodium salt anhydrous","Sodium clodronate hydrate","ZK 00091106","ZK-00091106"],"crossReferences":{"PubChem":["11112020","144203860","50106170","85231300"],"chEBI":["59586"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1524273","canonicalSmiles":"O=C(O)c1ccccc1C(=O)Nc1ccc(S(=O)(=O)Nc2nccs2)cc1","inchiKey":"PBMSWVPMRUJMPE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHTHALYLSULFATHIAZOLE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Thalazole"],"synonyms":["Phthalylsulfathiazole","Phthalylsulfhathiazole","Phthalylsulphathiazole","Sulfaphtalylthiazol"],"crossReferences":{"PubChem":["11112227","144203931","170466178","56463086"],"drugbank":["DB13248"],"chEBI":["9336"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1537","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)O","inchiKey":"JTWOMNBEOCYFNV-NFFDBFGFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZLOCILLIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Azlin"],"synonyms":["Azlocillin"],"crossReferences":{"Wikipedia":["Azlocillin"],"drugbank":["DB01061"],"chEBI":["2956"]},"childChemblIds":["CHEMBL1201041"],"count":1,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for bacterial disease."}
{"id":"CHEMBL1641","canonicalSmiles":"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)COP(=O)(O)O","inchiKey":"BGSOJVFOEQLVMH-VWUMJDOOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCORTISONE PHOSPHORIC ACID","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hydrocortisone phosphate"],"crossReferences":{"PubChem":["50112718"],"drugbank":["DB14542"],"chEBI":["68634"]},"childChemblIds":["CHEMBL1200968"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0009552","HP_0004798","EFO_0005752"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960."}
{"id":"CHEMBL1697825","canonicalSmiles":"CCCCN(CCCC)CCNc1nc(-c2ccccc2)no1","inchiKey":"VYWQZAARVNRSTR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTALAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Butalamine","LA 1221 [AS HYDROCHLORIDE]"],"crossReferences":{"drugbank":["DB13681"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1697828","canonicalSmiles":"CCC(Br)(CC)C(=O)NC(N)=O","inchiKey":"OPNPQXLQERQBBV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBROMAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Adalin"],"synonyms":["Bromodiethylacetylurea","Carbromal"],"crossReferences":{"PubChem":["144212564"],"Wikipedia":["Carbromal"],"drugbank":["DB13817"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1697832","canonicalSmiles":"C[C@]12C[C@H](O)[C@H]3[C@@H](C=C(Cl)C4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO","inchiKey":"YTJIBEDMAQUYSZ-FDNPDPBUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOPREDNOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Cloradryn"],"synonyms":["Cloprednol","RS-4691"],"crossReferences":{"drugbank":["DB13843"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1732","canonicalSmiles":"CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21","inchiKey":"LUZRJRNZXALNLM-JGRZULCMSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DIHYDROERGOTAMINE","yearOfFirstApproval":1946,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dihydroergotamine","MAP-0004","MAP0004"],"crossReferences":{"DailyMed":["dihydroergotamine%20mesylate"],"PubChem":["104171355","124883195","144204372","170465012","26751735","50104427","90341683"],"Wikipedia":["Dihydroergotamine"],"drugbank":["DB00320"],"chEBI":["4562"]},"childChemblIds":["CHEMBL1200517"],"count":3,"approvedIndications":["EFO_0003821"],"linkedTargets":{"rows":["ENSG00000179546"],"count":1},"linkedDiseases":{"rows":["EFO_0005296","EFO_0003821","EFO_0005295"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1946 and is indicated for migraine disorder and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL173373","canonicalSmiles":"CCOC(=O)C(C)=O","inchiKey":"XXRCUYVCPSWGCC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHYL PYRUVATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Oxo-Propionic Acid Ethyl Ester","CTI-01","Ethyl pyruvate","FEMA NO. 2457","NSC-48386","Pyruvic acid ethyl ester"],"crossReferences":{"drugbank":["DB05869"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1741","canonicalSmiles":"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O","inchiKey":"AGOYDEPGAOXOCK-KCBOHYOISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLARITHROMYCIN","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Biaxin","Biaxin Xl Pac","Biaxin xl","Clarie xl","Clarithromycin","Clarithromycin Extended Release","Clarosip","Febzin xl","Klaricid","Klaricid 500","Klaricid adult","Klaricid i.v.","Klaricid paed","Klaricid xl","Mycifor xl","Xetinin xl","Zeclar"],"synonyms":["A-56268","ABBOTT-56268","Biaxin","Clarithromycin","Clarithromycin identity","Prevpac","TE-031"],"crossReferences":{"DailyMed":["clarithromycin"],"PubChem":["26719890","49648843"],"drugbank":["DB01211"],"chEBI":["3732"]},"count":43,"approvedIndications":["EFO_0003106","EFO_0000771","EFO_0000544","EFO_0004607"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 4 approved and 39 investigational indications."}
{"id":"CHEMBL1743005","drugType":"Antibody","blackBoxWarning":false,"name":"DACETUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dacetuzumab","HU-S2C6","HUS2C6","SGN-40"],"count":4,"linkedTargets":{"rows":["ENSG00000101017"],"count":1},"linkedDiseases":{"rows":["EFO_0000095","EFO_0000403","EFO_0001378","EFO_0005952"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL175970","canonicalSmiles":"N[C@@H](CSCP(=O)(O)O)C(=O)O","inchiKey":"IIALWEPLPCANHU-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL175970","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02461"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1768","canonicalSmiles":"CC(C[N+](C)(C)C)OC(N)=O.[Cl-]","inchiKey":"XXRMYXBSBOVVBH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETHANECHOL CHLORIDE","yearOfFirstApproval":1948,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1482","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bethanechol chloride","Duvoid","Myocholine","Myotonachol","Myotonine","Urecholine"],"synonyms":["Bethanechol Chloride","Bethanechol chloride","Carbamylmethylcholine chloride","NSC-30783"],"crossReferences":{"DailyMed":["bethanechol%20chloride"],"PubChem":["144205581","26747481","50106064","56422417","855684"],"chEBI":["3085"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1948."}
{"id":"CHEMBL1771","canonicalSmiles":"COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1","inchiKey":"GKTWGGQPFAXNFI-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CLOPIDOGREL","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Grepid","Iscover","Plavix"],"synonyms":["Clopidogrel","R 130964","R-130964","SR 25990","SR-25990"],"crossReferences":{"DailyMed":["clopidogrel%20bisulfate"],"PubChem":["49666065","49666423"],"Wikipedia":["Clopidogrel"],"drugbank":["DB00758"],"chEBI":["37941"]},"childChemblIds":["CHEMBL1083385"],"count":42,"approvedIndications":["MONDO_0000831","HP_0004419"],"linkedTargets":{"rows":["ENSG00000169313"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0003777","EFO_0001361","HP_0002239","EFO_0000275","MONDO_0002009","EFO_0000266","EFO_0003913","EFO_0003914","EFO_0008585","EFO_0003870","EFO_0002690","EFO_0003884","EFO_0007541","EFO_0000400","EFO_1000059","EFO_0009686","HP_0001685","EFO_0003821","EFO_0000180","EFO_0004286","EFO_0004607","EFO_0002429","MP_0001914","MONDO_0100096","MONDO_0000831","EFO_0000270","EFO_0007328","EFO_0001360","EFO_1000860","EFO_0005672","HP_0030680","MONDO_0002679","EFO_0003876","EFO_0002950","MONDO_0001056","EFO_1000044","EFO_1001216","EFO_0003144","EFO_0000712","HP_0004419","EFO_0006859","HP_0002140","EFO_0000545","EFO_0003875","EFO_0001645","EFO_0000556","EFO_0009315","GO_0070527","EFO_0004277","EFO_0000319","EFO_0002615","EFO_0000537","EFO_0003106","EFO_0000195","EFO_1000881","EFO_0003764","EFO_1000985","EFO_0000764","EFO_0009086","EFO_0008583","EFO_0000612","EFO_1001207","EFO_0004265","EFO_0004264"],"count":65},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for recurrent thrombophlebitis and thrombotic disease and has 40 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL177820","canonicalSmiles":"Brc1c(Br)c(Br)c2[nH]nnc2c1Br","inchiKey":"OMZYUVOATZSGJY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRABROMOBENZOTRIAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4,5,6,7-Tetrabromobenzotriazole"],"crossReferences":{"PubChem":["26753256","26753257","90341691"],"drugbank":["DB04462"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL178654","canonicalSmiles":"CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C","inchiKey":"NERXPXBELDBEPZ-RMKNXTFCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HKI-357","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hki-357"],"crossReferences":{"drugbank":["DB13002"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1788404","canonicalSmiles":"C[N+](C)(CCOc1ccccc1)Cc1ccccc1","inchiKey":"AVWWVJUMXRXPNF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEPHENIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bephenium"],"crossReferences":{"drugbank":["DB13462"]},"childChemblIds":["CHEMBL3391735"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1789843","drugType":"Antibody","blackBoxWarning":false,"name":"BELIMUMAB","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Benlysta","Lymphostat-b","Lymphostat-b benlysta"],"synonyms":["BEL-114333","BEL114333","Belimumab","Belimumab (genetical recombination)","GSK-1550188","GSK1550188","HGS-1006","HGS1006"],"crossReferences":{"DailyMed":["belimumab"],"DrugCentral":["4949"]},"count":13,"approvedIndications":["EFO_0002690","EFO_0000540"],"linkedTargets":{"rows":["ENSG00000102524"],"count":1},"linkedDiseases":{"rows":["MONDO_0013730","EFO_0003086","EFO_0000685","EFO_0005761","EFO_0000464","EFO_0000540","EFO_0006803","EFO_0007160","EFO_0004254","EFO_0002690","MONDO_0017287","EFO_0000783","EFO_0000717","EFO_0000699"],"count":14},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for immune system disease and systemic lupus erythematosus and has 11 investigational indications."}
{"id":"CHEMBL184151","canonicalSmiles":"N#CCc1cc(O)cc2cc(-c3ccc(O)cc3)oc12","inchiKey":"ZKJVCUXZMYKTLT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL184151","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06927"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL186422","canonicalSmiles":"O=c1ccc2ccccc2[nH]1","inchiKey":"LISFMEBWQUVKPJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-Hydroxyquinoline","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Hydroxyquinoline","Quinolin-2-ol"],"crossReferences":{"PubChem":["29217777"],"drugbank":["DB04745"],"chEBI":["16365"]},"childChemblIds":["CHEMBL1673272"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1884070","canonicalSmiles":"C[C@H](CCC(=O)[O-])[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@@]21C.O.[Na+]","inchiKey":"NDVHNZISGVSFMP-WTCAICSISA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1884070","maximumClinicalTrialPhase":0,"parentId":"CHEMBL406393","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["93576918"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL190467","canonicalSmiles":"O=C1C(c2ccc(O)cc2)=C(Br)c2ccc(O)cc21","inchiKey":"DHPCBFMFERFZLR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL190467","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07230"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL191146","canonicalSmiles":"CCCc1c(SC2CCCCC2)c2cc(Cl)ccc2[nH]c1=O","inchiKey":"CLKFNGKDJYMUPK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL191146","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07868"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1950553","canonicalSmiles":"Nc1nc(OCCc2ccc(Cl)cc2)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"WUCQGGOGHZRELS-LSCFUAHRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SONEDENOSON","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MRE-0094","MRE0094","Mre0094","Sonedenoson"],"crossReferences":{"drugbank":["DB12443"]},"count":1,"linkedTargets":{"rows":["ENSG00000128271"],"count":1},"linkedDiseases":{"rows":["EFO_1001459"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2022742","canonicalSmiles":"Cl.Nc1c(Cl)cc(-c2nn(C3CCN(CCc4ccccc4)CC3)c(=O)o2)c2c1OCCO2","inchiKey":"LNNFXZHLRNQJIT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2022742","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2027925","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2048409","canonicalSmiles":"CS(=O)(=O)c1cccc(C[C@H](NC(=O)c2c(Cl)cc3c(c2Cl)CCN(C(=O)c2ccc4ccoc4c2)C3)C(=O)[O-])c1.[Na+]","inchiKey":"BPWOKOSRORLLIN-BQAIUKQQSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"LIFITEGRAST SODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2048028","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lifitegrast sodium","SAR 1118-023"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2051958","canonicalSmiles":"N=C(N)NCCN1CCCCCCC1.N=C(N)NCCN1CCCCCCC1.O=S(=O)(O)O","inchiKey":"NBJGGHFXCGHTNJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANETHIDINE SULFATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL765","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Guanethidine sulfate","SU-5864"],"crossReferences":{"chEBI":["51017"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL206834","canonicalSmiles":"Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1","inchiKey":"ZGBAJMQHJDFTQJ-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BAFETINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bafetinib","CNS-9","INNO-406","NS-187"],"crossReferences":{"drugbank":["DB11851"]},"count":2,"linkedTargets":{"rows":["ENSG00000097007","ENSG00000254087"],"count":2},"linkedDiseases":{"rows":["EFO_0000095","MONDO_0008315"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2103741","canonicalSmiles":"N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)[O-].O.[Na+]","inchiKey":"ANMYAHDLKVNJJO-LTCKWSDVSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"LEVOTHYROXINE SODIUM","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1624","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eltroxin","Euthyrox","Evotrox","L-thyroxine henning","Levo-t","Levolet","Levothroid","Levothyroid","Levothyroxine sodium","Levoxine","Levoxyl","Novothyrox","Soloxine","Synthroid","Thyro-tabs","Thyrol L","Thyroxine","Tirosint","Tirosint-sol","Unithroid"],"synonyms":["Levothyroxine sodium","Levothyroxine sodium hydrate","NSC-259940","T4","T4 (liotrix)","Thyroxine","Thyroxine sodium salt"],"crossReferences":{"DailyMed":["levothyroxine%20sodium"],"chEBI":["6447"]},"count":5,"approvedIndications":["Orphanet_442","EFO_0002892","EFO_0004705"],"linkedTargets":{"rows":["ENSG00000126351","ENSG00000151090"],"count":2},"linkedDiseases":{"rows":["EFO_0006859","EFO_0000289","Orphanet_442","EFO_0002892","EFO_1001062","EFO_0003843","EFO_0004705"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 3 approved and 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2103880","canonicalSmiles":"CN(C)CCCOc1ccc2[nH]nc(S(=O)(=O)c3cccc4ccccc34)c2c1","inchiKey":"NXQGEDVQXVTCDA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CERLAPIRDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cerlapirdine","PF-05212365","SAM-531","SAM-531 FREE BASE","Sam-531","WAY-262,531","WAY-262531"],"crossReferences":{"drugbank":["DB12229"]},"childChemblIds":["CHEMBL2105752"],"count":1,"linkedTargets":{"rows":["ENSG00000158748"],"count":1},"linkedDiseases":{"rows":["EFO_0000249"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2103920","canonicalSmiles":"CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)CSSC[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)CNC1=O","inchiKey":"IUCCYQIEZNQWRS-DWWHXVEHSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ULARITIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ularitide","Urodilatin ularitide"],"crossReferences":{"drugbank":["DB05034"]},"count":2,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2104207","canonicalSmiles":"CC(NCCn1cnc2c1c(=O)n(C)c(=O)n2C)C(O)c1ccccc1","inchiKey":"UJSKUDDDPKGBJY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAFEDRINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cafedrine"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104262","canonicalSmiles":"Oc1ccc2c(c1)C(Cc1c[nH]cn1)CC2","inchiKey":"VTZPAJGVRWKMAG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FADOLMIDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fadolmidine","Radolmidine"],"childChemblIds":["CHEMBL2106710"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2104585","canonicalSmiles":"CC(C)c1cc2c(cc1S(=O)(=O)O)[C@@]1(C)CCC[C@@](C)(C(=O)O)[C@@H]1CC2","inchiKey":"IWCWQNVIUXZOMJ-MISYRCLQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ECABET","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ecabet","Ecabet sodium"],"crossReferences":{"PubChem":["144206316"],"drugbank":["DB05265"]},"childChemblIds":["CHEMBL3343738","CHEMBL3186947","CHEMBL4303208"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2104985","canonicalSmiles":"N.Nc1nc(N)c2nc(CNc3ccc(C(=O)N[C@@H](CCCNC(=O)c4ccccc4C(=O)O)C(=O)O)cc3)cnc2n1","inchiKey":"CURXCENNYPPKOS-FYZYNONXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALOTREXIN AMMONIUM","maximumClinicalTrialPhase":1,"parentId":"CHEMBL590985","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-712783","PT-523","PT523","Talotrexin ammonium"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2105804","canonicalSmiles":"Cc1cc(C)c2c3ccccc3n(Cc3cccc([C@@H](C(=O)N[C@@H](CO)c4ccccc4)C4CCCC4)c3)c2n1","inchiKey":"AMNXBQPRODZJQR-DITALETJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMPLITAPIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY-13-9952","Implitapide"],"crossReferences":{"drugbank":["DB04852"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2106265","canonicalSmiles":"CC(C=C(c1cccs1)c1cccs1)N(C)C","inchiKey":"CANBGVXYBPOLRR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHYLTHIAMBUTENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dimethylthiambutene"],"crossReferences":{"drugbank":["DB01444"],"chEBI":["59781"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107819","canonicalSmiles":"CCO[C@@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)c1ccc(N)c(Cl)c1)C(C)(C)C","inchiKey":"SJDDOCKBXFJEJB-MOKWFATOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BELNACASAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Vx-765"],"synonyms":["Belnacasan","VX-765"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2107859","drugType":"Unknown","blackBoxWarning":false,"name":"ROZROLIMUPAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rozrolimupab","SYM-001","SYM001"],"count":1,"linkedTargets":{"rows":["ENSG00000187010"],"count":1},"linkedDiseases":{"rows":["EFO_0007160"],"count":1},"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2107867","drugType":"Cell","blackBoxWarning":false,"name":"CENPLACEL-L","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cenplacel","Cenplacel-l","PDA001"],"count":3,"description":"Cell drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2107885","drugType":"Enzyme","blackBoxWarning":false,"name":"RETEPLASE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rapilysin","Retavase"],"synonyms":["BM 06.022","BM-06.022","BM-06022","Reteplase"],"crossReferences":{"DailyMed":["reteplase"],"DrugCentral":["5044"]},"count":3,"approvedIndications":["HP_0004419"],"linkedTargets":{"rows":["ENSG00000122194"],"count":1},"linkedDiseases":{"rows":["EFO_0000712","EFO_0008583","EFO_0000612","HP_0004419"],"count":4},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for recurrent thrombophlebitis and has 2 investigational indications."}
{"id":"CHEMBL2108119","drugType":"Antibody","blackBoxWarning":false,"name":"PASCOLIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANTI-IL4","Pascolizumab","SB-240683"],"count":2,"linkedTargets":{"rows":["ENSG00000113520"],"count":1},"linkedDiseases":{"rows":["EFO_0000270","Orphanet_3389"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108171","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"ABETIMUS","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abetimus"],"count":1,"description":"Oligonucleotide drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2108290","drugType":"Protein","blackBoxWarning":false,"name":"EPOETIN THETA","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eporatio"],"synonyms":["Epoetin theta"],"crossReferences":{"DrugCentral":["5007"]},"description":"Protein drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2108594","drugType":"Protein","blackBoxWarning":false,"name":"EPTOTERMIN ALFA","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bone morphogenetic protein 7","Eptotermin alfa"],"crossReferences":{"DrugCentral":["5175"]},"count":2,"approvedIndications":["EFO_0004260"],"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and is indicated for bone disease and has 1 investigational indication."}
{"id":"CHEMBL2108708","drugType":"Antibody","blackBoxWarning":false,"name":"YTTRIUM Y 90 CLIVATUZUMAB TETRAXETAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Hpam4-cide"],"synonyms":["90HY-PAM4","90Y-HPAM4","90Y-HPAMA4","HPAM-4-DOTA","HPAM-DOTA HY-PAM4","HPAM4-DOTA","IMMU-107","S9S0HY-PAM4","Yttrium (90y) clivatuzumab tetraxetan","Yttrium y 90 clivatuzumab tetraxetan"],"count":1,"linkedTargets":{"rows":["ENSG00000215182"],"count":1},"linkedDiseases":{"rows":["EFO_0002618"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108956","drugType":"Unknown","blackBoxWarning":false,"name":"HYPROMELLOSE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Artelac","Artelac sdu","Brolene","Dacriosol","Genteal","Goniosol","Isopto tears","Methocel e, f, j, k","Moisture-eyes","Tearisol","Tears naturale","Ultra tears"],"synonyms":["Hydroxypropyl methylcellulose","Hydroxypropylmethylcellulose","Hypromellose","Methylcellulose, propylene glycol ether of","Propylene glycol ether of methylcellulose"],"count":5,"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2109056","drugType":"Unknown","blackBoxWarning":false,"name":"ECHINACEA PURPUREA, POWDERED","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Echinacea purpurea, powdered"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109212","drugType":"Protein","blackBoxWarning":false,"name":"PROINSULIN HUMAN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-167005","LY167005","Proinsulin","Proinsulin human"],"count":1,"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109519","drugType":"Antibody","blackBoxWarning":false,"name":"ABX-MA1","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABX-MA1"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109575","drugType":"Antibody","blackBoxWarning":false,"name":"BIIB-015","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIB-015","Biib-015"],"count":1,"linkedTargets":{"rows":["ENSG00000241186"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109591","drugType":"Antibody","blackBoxWarning":false,"name":"TOL-101","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TOL-101","TOL101","Tol-101"],"count":1,"linkedTargets":{"rows":["ENSG00000211699","ENSG00000277734","ENSG00000278030","ENSG00000211810"],"count":4},"linkedDiseases":{"rows":["EFO_0003884"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2110627","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CS[C@H](c2cccs2)CN(CC(=O)O)C1=O","inchiKey":"FIQOFIRCTOWDOW-BJLQDIEVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEMOCAPRIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Temocapril"],"crossReferences":{"drugbank":["DB08836"]},"childChemblIds":["CHEMBL2104499"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2111076","canonicalSmiles":"CC(N)CCCC(C)(C)O","inchiKey":"LREQLEBVOXIEOM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEPTAMINOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Heptaminol"],"crossReferences":{"drugbank":["DB13574"]},"childChemblIds":["CHEMBL2107282"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2142592","canonicalSmiles":"CN(C(=O)c1ccc(F)cc1C(F)(F)F)C1CCN(c2nnc(-c3ccnn3C)c3ccccc23)CC1","inchiKey":"SZBGQDXLNMELTB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALADEGIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-2940680","LY2940680","Taladegib"],"crossReferences":{"PubChem":["137276014"],"drugbank":["DB12550"]},"count":3,"linkedTargets":{"rows":["ENSG00000128602"],"count":1},"linkedDiseases":{"rows":["EFO_0000702","EFO_0000311","EFO_0009708"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL218289","canonicalSmiles":"C[C@H](CCc1ccc(C(N)=O)cc1)NCC(=O)c1ccc(F)cc1","inchiKey":"OIWWNWQZJJKBTR-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL218289","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08672"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL21932","canonicalSmiles":"COc1ccc(C(=O)O)cc1","inchiKey":"ZEYHEAKUIGZSGI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"p-ANISIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Methoxy-Benzoic Acid","4-Methoxybenzoate","4-Methoxybenzoic Acid","P-Methoxybenzoic Acid"],"crossReferences":{"Wikipedia":["P-Anisic_acid"],"drugbank":["DB02795"],"chEBI":["40813"]},"childChemblIds":["CHEMBL1762657"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL220087","canonicalSmiles":"Oc1c(Br)cc(Br)cc1Br","inchiKey":"BSWWXRFVMJHFBN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2,4,6-Tribromophenol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2,4,6-Tribromophenol"],"crossReferences":{"PubChem":["144204649","144208471","144213289","170466870","17389588","26752930","56463483"],"Wikipedia":["2,4,6-Tribromophenol"],"drugbank":["DB02417"],"chEBI":["47696"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2221249","canonicalSmiles":"CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O","inchiKey":"JORAUNFTUVJTNG-BSTBCYLQSA-N","drugType":"Protein","blackBoxWarning":false,"name":"COLISTIN","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Colistin","Polymyxin E"],"crossReferences":{"DrugCentral":["4425"]},"childChemblIds":["CHEMBL2218908"],"count":9,"approvedIndications":["EFO_0000771"],"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1962 and is indicated for bacterial disease and has 8 investigational indications."}
{"id":"CHEMBL222838","canonicalSmiles":"NCCC[C@](N)(C(=O)O)C(F)F","inchiKey":"VLCYCQAOQCDTCN-ZCFIWIBFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-EFLORNITHINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-Eflornithine"],"crossReferences":{"drugbank":["DB03856"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2325741","canonicalSmiles":"NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1","inchiKey":"JDUBGYFRJFOXQC-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAPIVASERTIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZC5363","AZD-5363","AZD5363","Azd 5363","Azd-5363","Capivasertib"],"crossReferences":{"drugbank":["DB12218"]},"count":16,"linkedTargets":{"rows":["ENSG00000105221","ENSG00000117020","ENSG00000142208"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_0005232","Orphanet_145","EFO_0003869","EFO_1001958","EFO_0000503","MONDO_0015686","MONDO_0008170","MONDO_0007254","EFO_0000228","MONDO_0008315","EFO_0003060","EFO_0000311","MONDO_0001056","MONDO_0002974","MONDO_0011962","EFO_1000251","EFO_0000673","EFO_0001378","EFO_0000707"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 16 investigational indications."}
{"id":"CHEMBL2361641","canonicalSmiles":"CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C6CCCCC6)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\\C=C\\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O","inchiKey":"QLFZZSKTJWDQOS-YDBLARSUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DORAMECTIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Doramectin","UK-67,994"],"crossReferences":{"PubChem":["144206992"],"drugbank":["DB11400"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2364607","canonicalSmiles":"O=C(O)/C=C/C(=O)O.O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1.O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1","inchiKey":"RESIMIUSNACMNW-BXRWSSRYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COBIMETINIB FUMARATE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2146883","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cotellic"],"synonyms":["Cobimetinib fumarate"],"crossReferences":{"DailyMed":["cobimetinib%20fumarate"]},"count":1,"approvedIndications":["EFO_0002617"],"linkedTargets":{"rows":["ENSG00000126934","ENSG00000169032"],"count":2},"linkedDiseases":{"rows":["EFO_0002617"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2015 and is indicated for metastatic melanoma."}
{"id":"CHEMBL2364665","drugType":"Small molecule","blackBoxWarning":false,"name":"ASTODRIMER","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Vivagel"],"synonyms":["6436 (NIH Compound Number)","Astodrimer","BRI 7013","BRI-7013","BRI7013","SPL 7013","SPL-7013","SPL7013"],"crossReferences":{"DrugCentral":["5050"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2374220","canonicalSmiles":"COC(=O)N[C@H](C(=O)N1CC2(CC2)C[C@H]1c1nc(-c2ccc3c(c2)C(F)(F)c2cc(-c4ccc5[nH]c([C@@H]6[C@H]7CC[C@H](C7)N6C(=O)[C@@H](NC(=O)OC)C(C)C)nc5c4)ccc2-3)c[nH]1)C(C)C","inchiKey":"VRTWBAAJJOHBQU-KMWAZVGDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEDIPASVIR","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["GS-5885","Ledipasvir","Ledipasvir acetonate"],"crossReferences":{"DailyMed":["ledipasvir"],"drugbank":["DB09027"],"chEBI":["85089"]},"count":5,"approvedIndications":["EFO_0004220","EFO_0003047"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for hepatitis c virus infection and chronic hepatitis c virus infection and has 3 investigational indications."}
{"id":"CHEMBL2401777","canonicalSmiles":"C[C@@]1(C(=O)Nc2ccc([18F])nc2)CCCN1c1nc(Nc2cc(C3CC3)[nH]n2)c2cccn2n1","inchiKey":"LQVXSNNAFNGRAH-SXBFPYQPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2401777","maximumClinicalTrialPhase":0,"parentId":"CHEMBL575448","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL253825","canonicalSmiles":"CCOc1c(Cl)cc(N2CCCCC2)cc1NC(=O)c1cc(C)c(OCCN)c(C)c1","inchiKey":"CKBBGCJYKCLKHE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL253825","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07626"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL258208","canonicalSmiles":"O=P(O)(O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)COP(=O)(O)O","inchiKey":"WOYYTQHMNDWRCW-KVTDHHQDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Mannitol Bis-Phosphate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mannitol Bis-Phosphate"],"crossReferences":{"drugbank":["DB04733"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL261772","canonicalSmiles":"C=C1c2c(Cl)ccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@H]12.O=C(O)c1cc(S(=O)(=O)O)ccc1O","inchiKey":"FYSVKUUNXYGFLA-CCHMMTNSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MECLOCYCLINE SULFOSALICYLATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Meclan","Meclocil","Mecloderm","Meclosorb","Quoderm","Traumatociclina"],"synonyms":["Meclocycline 5-sulfosalicylate","Meclocycline sulfosalicylate","SNX-1012"],"crossReferences":{"PubChem":["144204345"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 2 investigational indications."}
{"id":"CHEMBL265720","canonicalSmiles":"c1ccc(-c2cc(-c3cc[nH]n3)on2)cc1","inchiKey":"SRSSTOPJERVMRZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL265720","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07613"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL272080","canonicalSmiles":"CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](N)C[C@H]2NC(=O)[C@@H](O)CN)OC[C@]1(C)O","inchiKey":"UDIIBEDMEYAVNG-ZKFPOVNWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISEPAMICIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Isepamicin","Isepamicin sulfate","SCH 21420"],"crossReferences":{"Wikipedia":["Isepamicin"],"drugbank":["DB13540"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL290106","canonicalSmiles":"Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O","inchiKey":"JFIOVJDNOJYLKP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BITHIONOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Dermatological toxicity"],"year":1967},"tradeNames":["Lorothidol"],"synonyms":["Bithionol"],"crossReferences":{"PubChem":["104171365","144204383","144207582","144213236","170465515","17389712","26751444","50100878","50123605","855531","99234233"],"Wikipedia":["Bithionol"],"drugbank":["DB04813"],"chEBI":["3131"]},"childChemblIds":["CHEMBL1447476"],"count":2,"approvedIndications":["EFO_1001342","EFO_0003894"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for acne and helminthiasis. It was withdrawn in United States  in 1967 due to Dermatological toxicity."}
{"id":"CHEMBL291386","canonicalSmiles":"COc1cc(C)c2ccc(O)c(C(=O)O[C@@H]3[C@@H](O)C=C[C@H]3O)c2c1","inchiKey":"XILHLKXLRFUQFI-QLPKVWCKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL291386","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08261"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL296435","canonicalSmiles":"CCCCCC[C@H]([C@H](C)O)n1cnc2c(N)ncnc21","inchiKey":"IOSAAWHGJUZBOG-WDEREUQCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(+)-EHNA","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07711"],"chEBI":["63059"]},"childChemblIds":["CHEMBL1995433"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL300461","canonicalSmiles":"CCCN(C)C(=O)[C@@H]1OC(C(=O)O)=C[C@H](NC(=N)N)[C@H]1NC(C)=O","inchiKey":"QPJWMZVTNXFTKV-JMJZKYOTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL300461","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03503"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039537","drugType":"Enzyme","blackBoxWarning":false,"name":"SEBELIPASE ALFA","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kanuma"],"synonyms":["SBC-102","Sebelipase alfa"],"crossReferences":{"DailyMed":["sebelipase%20alfa"],"DrugCentral":["5028"]},"count":3,"approvedIndications":["Orphanet_75234","Orphanet_275761"],"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for cholesteryl ester storage disease and lysosomal acid lipase deficiency and has 1 investigational indication."}
{"id":"CHEMBL306043","drugType":"Small molecule","blackBoxWarning":false,"name":"GOLD SODIUM THIOMALATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Myochrysine","Myocrisin"],"synonyms":["Aurothiomalate disodium","Gold sodium thiomalate","Sodium aurothiomalate"],"crossReferences":{"DrugCentral":["4706"],"chEBI":["38722"]},"count":2,"approvedIndications":["EFO_0005755"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for rheumatic disease and has 1 investigational indication."}
{"id":"CHEMBL3137744","canonicalSmiles":"OC[C@H](O)[C@H](O)[C@H](O)CO","inchiKey":"HEBKCHPVOIAQTA-ZXFHETKHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3137744","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14704"],"chEBI":["15963"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL317094","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1C(=O)N(C)C[C@H]1C(=O)O","inchiKey":"KLZWOWYOHUKJIG-BPUTZDHNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMIDAPRIL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tanatril"],"synonyms":["Imidapril","Imidapril hydrochloride"],"crossReferences":{"Wikipedia":["Imidapril"],"drugbank":["DB11783"]},"childChemblIds":["CHEMBL3183293"],"count":3,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_1002032","EFO_0000319","EFO_1001496"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cardiovascular disease and has 2 investigational indications."}
{"id":"CHEMBL3301610","canonicalSmiles":"CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1","inchiKey":"UZWDCWONPYILKI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABEMACICLIB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Verzenio","Verzenios"],"synonyms":["Abemaciclib","LY-2835219","LY2835219","Ly-2835219"],"crossReferences":{"DailyMed":["abemaciclib"],"drugbank":["DB12001"]},"childChemblIds":["CHEMBL4290012","CHEMBL4560869","CHEMBL4534140","CHEMBL4474565"],"count":36,"approvedIndications":["EFO_0000616","EFO_0003869","MONDO_0007254","EFO_0000305","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000135446","ENSG00000105810"],"count":2},"linkedDiseases":{"rows":["EFO_0005232","EFO_0003869","EFO_0000637","EFO_1001958","EFO_0000756","MONDO_0007254","EFO_1001469","EFO_0005952","EFO_0000305","EFO_0003085","EFO_0000632","EFO_1001951","MONDO_0001187","EFO_0000588","EFO_0000389","EFO_1001331","EFO_0000182","MONDO_0008903","EFO_0002918","EFO_0000616","EFO_0002618","EFO_0009780","MONDO_0002108","EFO_0000349","EFO_0000313","EFO_0003060","MONDO_0008315","EFO_0000621","EFO_0000311","EFO_0009708","EFO_1000026","MONDO_0015917","EFO_0000304","EFO_0000174","EFO_0002517","MONDO_0011962","EFO_0004284","EFO_0005701","EFO_0000574","EFO_0001378","MONDO_0024880","EFO_0003833","EFO_0000519","EFO_0000181","EFO_1000233"],"count":45},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 5 approved and 31 investigational indications."}
{"id":"CHEMBL3317856","canonicalSmiles":"O=c1ccc2ncc(=O)n3c2n1C[C@H]3CN1CCC(NCc2cc3c(cn2)OCCC3)CC1","inchiKey":"PZFAZQUREQIODZ-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GEPOTIDACIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-2140944","GSK2140944","Gepotidacin"],"crossReferences":{"drugbank":["DB12134"]},"childChemblIds":["CHEMBL3545364"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL338076","canonicalSmiles":"NC(=O)c1cn([C@@H](CO)CCn2ccc3ccc(NC(=O)CCc4ccccc4)cc32)cn1","inchiKey":"GUYYFMCFEPDDFL-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL338076","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07783"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL348000","canonicalSmiles":"O=C(O)c1cc(-c2ccccc2)nc2ccccc12","inchiKey":"YTRMTPPVNRALON-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CINCHOPHEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cinchophen","Phenylcinchoninic acid"],"crossReferences":{"PubChem":["104171373","124883499","124883501","144204392","144213983","170466318","26751442","4262559","50085459","855522"],"Wikipedia":["Cinchophen"],"drugbank":["DB13551"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3526419","canonicalSmiles":"O=C([C@@H]1C[C@H](N2CCN([14c]3ncccn3)CC2)CN1)N1CCC(F)(F)C1","inchiKey":"QWEWGXUTRTXFRF-SFSNIQJUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3526419","maximumClinicalTrialPhase":0,"parentId":"CHEMBL515387","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3527309","canonicalSmiles":"COc1cc2n[14cH]cc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O.CS(=O)(=O)O","inchiKey":"HWLFIUUAYLEFCT-ZMCFIIMUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3527309","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1289601","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544967","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-2256098","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gsk-2256098","Gsk2256098"],"count":3,"linkedTargets":{"rows":["ENSG00000169398"],"count":1},"linkedDiseases":{"rows":["EFO_1000044","EFO_0001361","Orphanet_2495","EFO_0000311"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3544984","canonicalSmiles":"O=C(c1ccccc1Cl)c1cccnc1-c1nnn(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c1-c1ccncc1","inchiKey":"CAVRKWRKTNINFF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRADIPITANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-686017","LY686017","Ly686017","Tradipitant","VLY-686"],"crossReferences":{"drugbank":["DB12580"]},"count":6,"linkedTargets":{"rows":["ENSG00000115353"],"count":1},"linkedDiseases":{"rows":["EFO_0006928","HP_0000989","MONDO_0100096","EFO_0000274","EFO_1001917","EFO_1000948","EFO_0003829"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL3545033","drugType":"Small molecule","blackBoxWarning":false,"name":"LY2828360","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-2828360","LY2828360","Ly2828360"],"count":1,"linkedTargets":{"rows":["ENSG00000188822"],"count":1},"linkedDiseases":{"rows":["EFO_0004616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545042","canonicalSmiles":"CC(C)c1cc2[nH]c(=O)n(NS(C)(=O)=O)c(=O)c2cc1-c1ccnn1C","inchiKey":"MCECSFFXUPEPDB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELURAMPANEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BGG-492","BGG492","Bgg492","Selurampanel"],"crossReferences":{"drugbank":["DB12367"]},"count":7,"linkedTargets":{"rows":["ENSG00000125675","ENSG00000120251","ENSG00000164418","ENSG00000171189","ENSG00000105737","ENSG00000149403","ENSG00000155511","ENSG00000152578","ENSG00000163873"],"count":9},"linkedDiseases":{"rows":["HP_0001257","EFO_0003885","HP_0000360","EFO_0000474","EFO_0003821","MONDO_0015643","HP_0001250"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL3545105","drugType":"Protein","blackBoxWarning":false,"name":"POL6326","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pol6326"],"count":8,"linkedTargets":{"rows":["ENSG00000121966"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0004251","EFO_0000339","EFO_0000095","MONDO_0007254","EFO_0000222","EFO_0001378","EFO_0000612","MONDO_0003541"],"count":9},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL3545405","drugType":"Small molecule","blackBoxWarning":false,"name":"BAY1067197","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY-10-67197","BAY-1067197","BAY10-67197","BAY1067197","Bay1067197","Neladenoson bialanate"],"count":1,"linkedTargets":{"rows":["ENSG00000163485"],"count":1},"linkedDiseases":{"rows":["EFO_0003144"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL361812","canonicalSmiles":"O=C(O)CCn1c2c(c3ccccc31)C[C@H](NS(=O)(=O)c1ccc(F)cc1)CC2","inchiKey":"LDXDSHIEDAPSSA-OAHLLOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAMATROBAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY U 3405","BAY-U-3405","EN 137774","EN-137774","Ramatroban"],"crossReferences":{"PubChem":["144206069","170465980"],"Wikipedia":["Ramatroban"],"drugbank":["DB13036"]},"count":1,"linkedTargets":{"rows":["ENSG00000006638","ENSG00000183134"],"count":2},"linkedDiseases":{"rows":["EFO_0000270"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL365617","canonicalSmiles":"CCNC(=O)c1n[nH]c(-c2cc(Cl)c(O)cc2O)c1-c1ccc(OC)cc1","inchiKey":"HUNAOTXNHVALTN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VER-49009","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["VER-49009"],"crossReferences":{"PubChem":["103905495"],"drugbank":["DB07495"],"chEBI":["47273"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707243","canonicalSmiles":"C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1.Cc1ccc(S(=O)(=O)[O-])cc1.O","inchiKey":"UOWOLENSDISMPG-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCOPYRRONIUM TOSYLATE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201335","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Qbrexza"],"synonyms":["DRM04","Glycopyrronium tosylate"],"crossReferences":{"DailyMed":["glycopyrronium%20tosylate"]},"count":1,"approvedIndications":["HP_0000975"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2018 and is indicated for hyperhidrosis."}
{"id":"CHEMBL3707399","drugType":"Small molecule","blackBoxWarning":false,"name":"CX1739","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cx1739"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL374936","canonicalSmiles":"C[C@H](c1nc(-c2ccc(S(C)(=O)=O)cc2)no1)[C@H](N)C(=O)N1CCCC1","inchiKey":"SQCDMTZMCHZYGO-FZMZJTMJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL374936","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07067"],"chEBI":["39955"]},"childChemblIds":["CHEMBL403415"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL376109","canonicalSmiles":"NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2OCCNCC2CCCNC2)[C@H](N)[C@@H](O)[C@@H]1O","inchiKey":"AHJDGUQMOYBKDU-NSCPTEJBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL376109","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04718"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833327","canonicalSmiles":"CC(=O)Nc1ccc(C(=O)O)cc1.CC(=O)Nc1ccc(C(=O)O)cc1.CC(=O)Nc1ccc(C(=O)O)cc1.CC(O)CN(C)C.CC(O)CN(C)C.CC(O)CN(C)C.O=c1[nH]cnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"YLDCUKJMEKGGFI-QCSRICIXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INOSINE PRANOBEX","maximumClinicalTrialPhase":4,"parentId":"CHEMBL3833405","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Imunovir"],"synonyms":["Inosine pranobex","Isoprinosine","NP-113","NPT-10381"],"crossReferences":{"DrugCentral":["4576"]},"count":1,"approvedIndications":["EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for viral disease."}
{"id":"CHEMBL3833368","canonicalSmiles":"CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)O)C(=O)C2.CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1","inchiKey":"INBJJAFXHQQSRW-STOWLHSFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUCAPARIB CAMSYLATE","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1173055","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rubraca"],"synonyms":["C0-338","CO-338","PF-1367338-BW","Rucaparib camsylate"],"crossReferences":{"DailyMed":["rucaparib%20camsylate"]},"count":2,"approvedIndications":["EFO_0001075"],"linkedTargets":{"rows":["ENSG00000143799","ENSG00000129484","ENSG00000041880"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_0001075","EFO_0000673"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and is indicated for ovarian carcinoma and has 1 investigational indication."}
{"id":"CHEMBL385517","canonicalSmiles":"N#C[C@@H]1C[C@@H]2C[C@@H]2N1C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2","inchiKey":"QGJUIPDUBHWZPV-SGTAVMJGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAXAGLIPTIN","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BMS-477118","BMS-477118-11","Saxagliptin"],"crossReferences":{"DailyMed":["saxagliptin%20hydrochloride"],"PubChem":["144206461"],"Wikipedia":["Saxagliptin"],"drugbank":["DB06335"],"chEBI":["71272"]},"childChemblIds":["CHEMBL2103745","CHEMBL1201743","CHEMBL3542376"],"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["EFO_1001459","EFO_1001121","EFO_0001359","EFO_0008583","EFO_0001360","EFO_0000400","EFO_0003940","EFO_0002546","HP_0012594","EFO_0000660"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2009."}
{"id":"CHEMBL39541","canonicalSmiles":"CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)c1nccs1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C","inchiKey":"OFDNQWIFNXBECV-VFSYNPLYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOLASTATIN-10","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dolastatin 10","Dolastatin-10","Dolostatin 10"],"crossReferences":{"drugbank":["DB12730"],"chEBI":["67357"]},"count":9,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL3989543","canonicalSmiles":"CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(N)=O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O","inchiKey":"COFJBSXICYYSKG-OAUVCNBTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VINDESINE SULFATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL238071","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eldisine"],"synonyms":["LY-099094","LY099094","NSC-245467","Vindesine sulfate","Vindesine sulfate salt"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL3989658","canonicalSmiles":"CS(=O)(=O)O.Nc1ncnc2c1ncn2CCOC[P@@]1(=O)OCC[C@@H](c2cccc(Cl)c2)O1","inchiKey":"JXQUAHHUSMJUFV-HZPZRMRQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRADEFOVIR MESYLATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2096895","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pradefovir mesilate","Pradefovir mesylate"],"crossReferences":{"drugbank":["DB05478"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL406270","canonicalSmiles":"O[C@@H](CS)[C@@H](O)CS","inchiKey":"VHJLVAABSRFDPM-IMJSIDKUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DITHIOTHREITOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dithiothreitol"],"crossReferences":{"Wikipedia":["Dithiothreitol"],"drugbank":["DB04447"],"chEBI":["42106"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4075711","canonicalSmiles":"CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@@H](C)O)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N([14CH3])C1","inchiKey":"OJMMVQQUTAEWLP-RXBOCRNOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4075711","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1447","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL417007","canonicalSmiles":"C[C@H](C[C@@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)CCC(=O)O)C(=O)O","inchiKey":"DOBNVUFHFMVMDB-BEFAXECRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LBQ-657","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lbq-657"],"crossReferences":{"drugbank":["DB14127"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL422668","canonicalSmiles":"NS(=O)(=O)N[C@@H](Cc1ccccc1)C(=O)O","inchiKey":"PHGMHLLGXKQIDY-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL422668","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03012"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297241","drugType":"Gene","blackBoxWarning":false,"name":"PEMLIMOGENE MEROLISBAC","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ADU-214","JNJ-64041757","Pemlimogene merolisbac"],"count":2,"description":"Gene drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297372","drugType":"Small molecule","blackBoxWarning":false,"name":"ATSM COPPER (II)","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atsm copper (ii)","Cu(ii)atsm"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297398","canonicalSmiles":"CCCc1c(OCc2ccc([C@H](O)c3cccc(C(=O)O)c3)cc2)ccc(C(C)=O)c1O","inchiKey":"DWQVYDLTPMGYNE-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-2300559","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY2300559","Ly-2300559","Ly2300559"],"crossReferences":{"drugbank":["DB13016"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297543","canonicalSmiles":"COCCCC(=O)NCc1ccc(C(F)(F)F)cc1","inchiKey":"QLZOWJNFLXSDSH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GET-73","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Get 73","Get-73"],"crossReferences":{"drugbank":["DB12928"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297598","canonicalSmiles":"C[C@@H](C(=O)Nc1ccc(Cl)cc1)C1CCC(c2ccnc3ccc(F)cc23)CC1","inchiKey":"KRTIYQIPSAGSBP-KLAILNCOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LINRODOSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS 986205","BMS-986205","Bms-986205","F 001287","F-001287","Linrodostat","ONO 7701","ONO-7701"],"childChemblIds":["CHEMBL4298147"],"count":8,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL4297763","drugType":"Unknown","blackBoxWarning":false,"name":"GTI-2040","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gti 2040","Gti-2040"],"count":5,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297819","drugType":"Unknown","blackBoxWarning":false,"name":"ROPEGINTERFERON ALFA-2B","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Aop2014","P1101","Ropeginterferon alfa-2b"],"count":5,"linkedTargets":{"rows":["ENSG00000159110","ENSG00000142166"],"count":2},"linkedDiseases":{"rows":["EFO_0004220","EFO_0000339","EFO_0000182","EFO_0007304","EFO_0002429","EFO_0004239","EFO_0000479"],"count":7},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297990","drugType":"Protein","blackBoxWarning":false,"name":"TEBENTAFUSP","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMCGP-100","IMCGP100","IMCgp 100","IMMTAC IMCGP100","Imcgp100","ImmTAC IMCgpgp 100","Tebentafusp"],"count":1,"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4298056","drugType":"Unknown","blackBoxWarning":false,"name":"IMMUNOCYTOKINE NHS-IL12","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Immunocytokine nhs-il12","M-9241","M9241","Nhs-il12"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4298072","drugType":"Unknown","blackBoxWarning":false,"name":"MARZEPTACOG ALFA (ACTIVATED)","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Marzeptacog alfa (activated)","PF-05280602","Pf-05280602"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298124","drugType":"Antibody","blackBoxWarning":false,"name":"DOSTARLIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dostarlimab","TSR-042","Tsr 042","Tsr-042","WBP-285"],"count":11,"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL4298130","drugType":"Antibody","blackBoxWarning":false,"name":"PLAMOTAMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Plamotamab","XENP13676","XMAB-13676","XmAb13676","Xmab13676"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298204","drugType":"Protein","blackBoxWarning":false,"name":"EFAVALEUKIN ALFA","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 592","AMG-592","Efavaleukin alfa"],"count":3,"description":"Protein drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL43280","canonicalSmiles":"CN","inchiKey":"BAVYZALUXZFZLV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methanaminium","Methylamine"],"crossReferences":{"Wikipedia":["Methylamine"],"drugbank":["DB01828"],"chEBI":["16830"]},"childChemblIds":["CHEMBL3560728"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL439009","canonicalSmiles":"O=c1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"HSCJRCZFDFQWRP-ABVWGUQPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL439009","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03501"],"chEBI":["67119"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL443052","canonicalSmiles":"OB1OCc2cc(F)ccc21","inchiKey":"LFQDNHWZDQTITF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAVABOROLE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kerydin"],"synonyms":["AN-2690","AN2690","Tavaborole"],"crossReferences":{"DailyMed":["tavaborole"],"PubChem":["174316125"],"drugbank":["DB09041"],"chEBI":["77942"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2014."}
{"id":"CHEMBL457","canonicalSmiles":"Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1","inchiKey":"HEMJJKBWTPKOJG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GEMFIBROZIL","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Emfib","Gemfibrozil","Lopid"],"synonyms":["CI-719","Gemfibrozil"],"crossReferences":{"DailyMed":["gemfibrozil"],"PubChem":["11112705","144204164","144209195","144213101","170464998","17389870","174007259","26751515","49718189","855780"],"TG-GATEs":["31"],"Wikipedia":["Gemfibrozil"],"drugbank":["DB01241"],"chEBI":["5296"]},"count":12,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000186951"],"count":1},"linkedDiseases":{"rows":["EFO_0003914","EFO_0004319","EFO_0004211","EFO_1001375","EFO_0000249","EFO_0001645","EFO_0000764","EFO_0003768","EFO_0004272","EFO_0000319","EFO_0001360","EFO_0000311","EFO_0003829"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and is indicated for cardiovascular disease and has 11 investigational indications."}
{"id":"CHEMBL4594263","drugType":"Unknown","blackBoxWarning":false,"name":"TOCOPHEROL HYDROCHLORIDE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Tocopherol hydrochloride"],"description":"Unknown drug with a maximum clinical trial phase of IV that was first approved in 2004."}
{"id":"CHEMBL4594270","canonicalSmiles":"CC(C)(NC(=O)O[C@@H]1CN2CCC1CC2)c1csc(-c2ccc(F)cc2)n1.O=C(O)CC(O)C(=O)O","inchiKey":"SQXUKOJKIWCALK-PKLMIRHRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VENGLUSTAT MALATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4297611","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GZ/SAR402671A","Genz-682452-AU","Gz/sar402671","SAR-402671 L-MALATE","SAR-402671A","SAR402671A","Venglustat l-malate","Venglustat malate"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594431","canonicalSmiles":"CNC(=O)c1cccc(-c2ccc3c(N4C5CCC4COC5)nc(N4CCOC[C@@H]4C)nc3n2)c1","inchiKey":"LVPBYQVQBZLDAU-DZIBYMRMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MTI-31","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LXI-15029","Lxi-15029","MTI-31","Mti-31","SCC-31"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594512","drugType":"Unknown","blackBoxWarning":false,"name":"WN-80E","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HBV-002 COMPONENT WN-80E","WN-80E","Wn-80e"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594614","drugType":"Unknown","blackBoxWarning":false,"name":"VIS-649","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["VIS-649","VIS649","Vis-649","Vis649"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL460702","canonicalSmiles":"CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1","inchiKey":"VNBRGSXVFBYQNN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-777607","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-777607","Bms-777607"],"crossReferences":{"PubChem":["137276001"],"drugbank":["DB12064"]},"count":1,"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL46740","canonicalSmiles":"Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12","inchiKey":"UCJGJABZCDBEDK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BAZEDOXIFENE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bazedoxifene"],"crossReferences":{"DailyMed":["bazedoxifene%20acetate"],"PubChem":["124893775"],"Wikipedia":["Bazedoxifene"],"drugbank":["DB06401"]},"childChemblIds":["CHEMBL2106615"],"count":5,"linkedTargets":{"rows":["ENSG00000091831","ENSG00000140009"],"count":2},"linkedDiseases":{"rows":["EFO_0000685","MONDO_0041161","EFO_0003854","MONDO_0007254","EFO_0000432","EFO_0003929","EFO_0003882","EFO_0001073","EFO_0003922"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL467754","canonicalSmiles":"CC(=O)N[C@H]1[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O)[C@H](NC(C)=O)[C@H]2O)O[C@H](CO)[C@@H](O)[C@@H]1O","inchiKey":"CDOJPCSDOXYJJF-KSKNGZLJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHITODEXTRIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chitodextrin"],"crossReferences":{"drugbank":["DB03013"],"chEBI":["50670"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL467888","canonicalSmiles":"C[C@@H]1CC[C@H]([C@@H](O)C(F)(F)F)N1c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1","inchiKey":"HWLLYFXDDGGHOE-BCSUUIJWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LGD-2941","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lgd-2941"],"crossReferences":{"drugbank":["DB05234"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL469448","canonicalSmiles":"OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O","inchiKey":"WQZGKKKJIJFFOK-QTVWNMPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D-MANNOSE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-mannose","Mannose","NSC-26247"],"crossReferences":{"PubChem":["29217866","56323500"],"Wikipedia":["Mannose"],"chEBI":["4208"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL473841","canonicalSmiles":"CN(CC(=O)NC(c1cccc([N+](=O)[O-])c1)c1cc(Cl)c2cccnc2c1O)c1ccccc1","inchiKey":"CBUQIOYQSSZVDA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AGG-523","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Agg-523","PF-05212371","PF-5212371","WAY-266523"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL479079","canonicalSmiles":"COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC","inchiKey":"SQQAPOSROFWHIB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GW612286X","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW612286X"],"crossReferences":{"PubChem":["124349985"],"drugbank":["DB08519"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL486422","canonicalSmiles":"O=c1c(-c2ccc(O)cc2)coc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc12","inchiKey":"KYQZWONCHDNPDP-QNDFHXLGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAIDZIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dadzin","Daidzin"],"crossReferences":{"PubChem":["17504729","26756915"],"Wikipedia":["Daidzin"],"drugbank":["DB02115"],"chEBI":["42202"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL488937","canonicalSmiles":"Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O","inchiKey":"YCLREGRRHGLOAK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CG-400549","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CG-400459","CG400549","Cg-400549","Cg400549"],"crossReferences":{"drugbank":["DB12347"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL494360","canonicalSmiles":"FC(F)(F)c1cccc(-c2nnc3ccc(NC4CCCCC4)nn23)c1","inchiKey":"XYYDXQCAYXOGQT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL494360","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08708"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL49943","canonicalSmiles":"c1ccc(C(CCN2CCCCC2)c2ccccc2)cc1","inchiKey":"JXJPYHDHJZJWRI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENPIPRANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fenpiprane"],"crossReferences":{"drugbank":["DB13439"]},"childChemblIds":["CHEMBL2106726"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL511942","canonicalSmiles":"Cc1cccc(CNC(=O)c2cc(C(=O)NCc3cccc(C)c3)ncn2)c1","inchiKey":"GTBUZLPQANSGGE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL511942","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04759"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL517140","canonicalSmiles":"CNC(=O)c1ccc(Oc2ccc3c(c2)CCN(C2CCC2)CC3)nc1","inchiKey":"WROHEWWOCPRMIA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK189254","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK189254","Gsk189254"],"crossReferences":{"Wikipedia":["GSK-189,254"]},"childChemblIds":["CHEMBL2031739"],"count":1,"linkedTargets":{"rows":["ENSG00000101180"],"count":1},"linkedDiseases":{"rows":["MONDO_0021107"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL537445","canonicalSmiles":"Br.CC(Cc1ccc(O)cc1)NCC(O)c1cc(O)cc(O)c1","inchiKey":"SGZRQMALQBXAIQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENOTEROL HBR","maximumClinicalTrialPhase":0,"parentId":"CHEMBL32800","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fenoterol HBr","Fenoterol Hydrobromide"],"crossReferences":{"PubChem":["144204132","170465657","26732605","26747517","50106336"],"chEBI":["31601"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL542620","canonicalSmiles":"Cl.NCC1(CC(=O)O)CCCCC1","inchiKey":"XBUDZAQEMFGLEU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL542620","maximumClinicalTrialPhase":0,"parentId":"CHEMBL940","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL54922","canonicalSmiles":"O=C(O)[C@@H]1CCCN1","inchiKey":"ONIBWKKTOPOVIA-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-Proline","Proline","Pyrrolidine-2-Carboxylic Acid"],"crossReferences":{"PubChem":["4253464"],"drugbank":["DB00172"],"chEBI":["17203"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL566752","canonicalSmiles":"CNc1ccc(/C=C/c2ccc(OCCOCCOCC[18F])cc2)cc1","inchiKey":"NCWZOASIUQVOFA-FWZJPQCDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLORBETABEN F18","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1908906","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Neuraceq"],"synonyms":["BAY-949172","Florbetaben (18f)","Florbetaben f-18","Florbetaben f18","UNII-TLA7312TOI"],"crossReferences":{"DailyMed":["florbetaben%20f-18"],"drugbank":["DB09148"],"chEBI":["79033"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2014."}
{"id":"CHEMBL582912","canonicalSmiles":"CC/C=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1csc(N)n1","inchiKey":"HJJRIJDTIPFROI-NVKITGPLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFCAPENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cefcapene"],"crossReferences":{"drugbank":["DB13461"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL61301","canonicalSmiles":"Fc1ccc(Cn2c(NC3CCNCC3)nc3ccccc32)cc1","inchiKey":"SFOVDSLXFUGAIV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TECASTEMIZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Norastemizole (trivial name)","R-43512","Tecastemizole"],"crossReferences":{"drugbank":["DB06457"]},"childChemblIds":["CHEMBL1788380"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL62492","canonicalSmiles":"CC(C)COc1cccc(-c2nc3cc(C(=N)N)c(Cl)cc3[nH]2)c1O","inchiKey":"RTSLVPMQUZXPBZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL62492","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02989"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL63323","canonicalSmiles":"O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1","inchiKey":"JZFPYUNJRRFVQU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIFLUMIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Niflumic acid","UP 83"],"crossReferences":{"PubChem":["104171198","11111518","11111519","124880841","124880844","124880846","144203757","170466463","26747041","26751559","50104166","56423150","85231149","855922","90341015"],"drugbank":["DB04552"],"chEBI":["34888"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL63893","canonicalSmiles":"N[C@@H](CCC(=O)NO)C(=O)O","inchiKey":"YVGZXTQJQNXIAU-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLUTAMINE HYDROXAMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glutamine Hydroxamate"],"crossReferences":{"drugbank":["DB02446"],"chEBI":["75305"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL656","canonicalSmiles":"COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314","inchiKey":"BRUQQQPBMZOVGD-XFKAJCMBSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"OXYCODONE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":["Oxycontin","Proladone","Xtampza er"],"synonyms":["IDS-NO-002","N02AA05","NSC-19043","Oxicone","Oxycodone","Oxycodone cii","PF-00345439","PTI-821"],"crossReferences":{"DailyMed":["oxycodone","oxycodone%20hydrochloride","oxycodone%20terephthalate"],"Wikipedia":["Oxycodone"],"drugbank":["DB00497"],"chEBI":["7852"]},"childChemblIds":["CHEMBL1200890","CHEMBL3989826"],"count":25,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003943","MONDO_0001583","HP_0000989","EFO_0007486","EFO_1001919","EFO_1001951","HP_0002018","EFO_0003931","EFO_0002506","EFO_1000786","EFO_0004253","EFO_0003884","EFO_0003100","EFO_0004616","HP_0003419","EFO_0001069","HP_0008419","EFO_1002012","EFO_0003877","EFO_0005762","HP_0012532","EFO_0004329","EFO_0002508","EFO_0010072","HP_0002571","HP_0003418","EFO_0010702","EFO_0003843","EFO_0000311","EFO_0003890","MONDO_0002491","EFO_0009842","HP_0030833","EFO_0004209","EFO_1000999","EFO_0005611","EFO_0004270","HP_0000023","EFO_0000668","HP_0002019"],"count":40},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and is indicated for pain and has 24 investigational indications. It was withdrawn in United States. This drug has a black box warning from the FDA."}
{"id":"CHEMBL65717","canonicalSmiles":"Cc1cc2c(OCC(O)CNC(C)C)cccc2[nH]1","inchiKey":"NXWGWUVGUSFQJC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPINDOLOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mepindolol"],"crossReferences":{"drugbank":["DB13530"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL6594","canonicalSmiles":"Cc1cc(CCCCCOc2c(Cl)cc(C3=NCCO3)cc2Cl)on1","inchiKey":"JJDHAOLOHQTGMG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"WIN-54954","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["WIN-54954"],"crossReferences":{"drugbank":["DB08723"],"chEBI":["10029"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL704","canonicalSmiles":"Nc1ccc(O)c(C(=O)O)c1","inchiKey":"KBOPZPXVLCULAV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MESALAMINE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Apriso","Asacol","Asacol hd","Canasa","Coltec ec","Delzicol","Ipocol","Lialda","Mesalamine","Mesren mr","Mezavant xl","Octasa","Pentasa","Pentasa sr","Rowasa","Salofalk","Sfrowasa"],"synonyms":["Fisalamine","MAX-002","Mesalamine","Mesalazine","Mesalazine ","NSC-38877"],"crossReferences":{"DailyMed":["mesalamine"],"PubChem":["104171289","11112235","144203935","144208808","144213442","170464840","17389224","26752847","49681712"],"Wikipedia":["Mesalazine"],"drugbank":["DB00244"],"chEBI":["6775"]},"count":16,"approvedIndications":["EFO_0000729"],"linkedTargets":{"rows":["ENSG00000132170","ENSG00000073756","ENSG00000012779","ENSG00000095303"],"count":4},"linkedDiseases":{"rows":["Orphanet_144","EFO_0000729","EFO_0000765","EFO_0008572","EFO_0000555","EFO_0005406","HP_0002253","EFO_1001294","EFO_0007168","EFO_0000384","EFO_1001293","HP_0004798","EFO_1001951","EFO_1001460","EFO_0009959","EFO_0000764","EFO_0003872","EFO_0005628"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and is indicated for ulcerative colitis and has 15 investigational indications."}
{"id":"CHEMBL70418","canonicalSmiles":"CN1C(=O)CC(=O)N(c2ccccc2)c2cc(Cl)ccc21","inchiKey":"CXOXHMZGEKVPMT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CLOBAZAM","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Frisium","Onfi","Perizam","Sympazan","Tapclob","Urbanyl"],"synonyms":["Clobazam","H 4723","H-4723","HR 376","HR-376","LM 2717","LM-2717","NSC-336279"],"crossReferences":{"DailyMed":["clobazam"],"PubChem":["144206161"],"Wikipedia":["Clobazam"],"drugbank":["DB00349"],"chEBI":["31413"]},"count":11,"approvedIndications":["EFO_0005230"],"linkedTargets":{"rows":["ENSG00000022355","ENSG00000182256","ENSG00000011677","ENSG00000113327","ENSG00000151834","ENSG00000163285","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0005762","EFO_0000474","MONDO_0002050","Orphanet_33069","EFO_1000924","HP_0000726","HP_0003419","Orphanet_2382","EFO_0005230","EFO_0000692","EFO_0003843"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and is indicated for anxiety and has 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL75013","canonicalSmiles":"O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)NCCCC2","inchiKey":"PMBLXLOXUGVTGB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZANAPEZIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TAK-147","Zanapezil"],"crossReferences":{"drugbank":["DB04859"]},"childChemblIds":["CHEMBL2358658"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL802","canonicalSmiles":"Nc1cc(N2CCCCC2)nc(N)[n+]1[O-]","inchiKey":"ZFMITUMMTDLWHR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MINOXIDIL","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Loniten","Lonolox","Men's rogaine","Minodyl","Minoxidil","Minoxidil (for men)","Minoxidil (for women)","Minoxidil extra strength (for men)","Regaine for men","Regaine for women","Rogaine","Rogaine (for men)","Rogaine (for women)","Rogaine extra strength (for men)","Theroxidil","Women's rogaine"],"synonyms":["Minoxidil","U-10,858","U-10858"],"crossReferences":{"DailyMed":["minoxidil"],"PubChem":["104171187","11111457","11111458","11113580","144203744","170464704","26751784","26751785","46500395","50104471","85231134","90340717"],"Wikipedia":["Minoxidil"],"drugbank":["DB00350"],"chEBI":["6942"]},"count":3,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000069431"],"count":1},"linkedDiseases":{"rows":["EFO_0005400","EFO_0004192","Orphanet_79364","MONDO_0022113","EFO_0004191","MONDO_0003037","EFO_0000537"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1979 and is indicated for hypertension and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL830","canonicalSmiles":"NCCCC(N)(C(=O)O)C(F)F","inchiKey":"VLCYCQAOQCDTCN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EFLORNITHINE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Eflornithine","Ornidyl","Vaniqa"],"crossReferences":{"DailyMed":["eflornithine%20hydrochloride"],"PubChem":["174006789","575150","90341137"],"Wikipedia":["Eflornithine"],"drugbank":["DB06243"],"chEBI":["41948"]},"childChemblIds":["CHEMBL536971","CHEMBL1201037"],"count":17,"approvedIndications":["DOID_10113","EFO_0005044"],"linkedTargets":{"rows":["ENSG00000115758"],"count":1},"linkedDiseases":{"rows":["MONDO_0021440","DOID_10113","EFO_0005044","MONDO_0007576","EFO_0000313","EFO_0000502","EFO_0000621","MONDO_0008315","EFO_0005225","EFO_1001951","MONDO_0001187","MONDO_0001056","EFO_0009260","MONDO_0002974","Orphanet_733","MONDO_0021074","EFO_0004142","EFO_0002499"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and is indicated for leishmaniasis and trypanosomiasis and has 15 investigational indications."}
{"id":"CHEMBL857","canonicalSmiles":"O=C(O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12","inchiKey":"YBJHBAHKTGYVGT-ZKWXMUAHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIOTIN","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bioepiderm","Biotin 100","Vitamin H"],"synonyms":["Biotin","MD-1003","NSC-63865"],"crossReferences":{"DailyMed":["biotin"],"PubChem":["144206601","144212478","170464763","47193878","49674668"],"Wikipedia":["Biotin"],"drugbank":["DB00121"],"chEBI":["15956"]},"count":8,"approvedIndications":["EFO_0003884","EFO_0004272","EFO_0001360","HP_0001891"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 4 approved and 4 investigational indications."}
{"id":"CHEMBL862","canonicalSmiles":"N=C(N)NC(=O)Cc1c(Cl)cccc1Cl","inchiKey":"INJOMKTZOLKMBF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANFACINE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Intuniv"],"synonyms":["Guanfacine","Tenex"],"crossReferences":{"DailyMed":["guanfacine%20hydrochloride"],"PubChem":["104171166","11111221","11111222","11113866","124880211","26752038","90341397"],"Wikipedia":["Guanfacine"],"drugbank":["DB01018"],"chEBI":["5558"]},"childChemblIds":["CHEMBL1200494"],"count":14,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["EFO_0003888","EFO_0003756","EFO_0004319","EFO_0002610","EFO_1001219","HP_0012532","MONDO_0002009","EFO_0004329","MONDO_0001087","EFO_0000249","EFO_0003768","EFO_0001358","EFO_0009267","EFO_0003829","EFO_0000537","EFO_0007191","HP_0100543","EFO_0003890","HP_0012075","EFO_0004895","EFO_0000712","EFO_0003918","EFO_0005411","EFO_0000692"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and is indicated for hypertension and has 13 investigational indications."}
{"id":"CHEMBL96","canonicalSmiles":"NCCCC(=O)O","inchiKey":"BTCSSZJGUNDROE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GAMMA-AMINOBUTYRIC ACID","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".gamma.-aminobutyric acid","Aminobutyric acid","Gamma-aminobutyric acid","NSC-27418","Vigabatrin impurity, .gamma.-aminobutyric acid-"],"crossReferences":{"PubChem":["104171103","11110722","11113457","144203622","26751685","50104376","8139983","85230901","90341695"],"Wikipedia":["Gamma-Aminobutyric_acid"],"drugbank":["DB02530"],"chEBI":["16865"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL985","canonicalSmiles":"NC(N)=O","inchiKey":"XSQUKJJJFZCRTK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UREA","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aquadrate","Balneum plus","Calmurid","Eucerin","Flexifoot","Flexitol","Hydromol intensive","Nutraplus","Sential e","St.james balm","Sterile urea","Ureaphil"],"synonyms":["Carbamide","E-927A","E927b","INS NO.927A","INS-927A","NSC-34375","Urea"],"crossReferences":{"DailyMed":["urea","urea,%20c-14"],"PubChem":["144204587","144209356","144210355","17389689","49640652"],"Wikipedia":["Urea"],"drugbank":["DB03904"],"chEBI":["16199"]},"childChemblIds":["CHEMBL3184026","CHEMBL2096648","CHEMBL2096635"],"count":11,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 11 investigational indications."}
